Prebiotic Effect of a Jelly Containing Short Chain Fructo-Oligosaccharides and Sideritis Euboea Extract
Impact of a Jelly Containing Short Chain Fructo-oligosaccharides and Sideritis Euboea Extract on Human Gut Microflora
1 other identifier
interventional
64
1 country
1
Brief Summary
The human intestinal microflora is characterized as a complex and dynamic microbial ecosystem with crucial contribution to our nutrition and welfare. Health-promoting genera such as Bifidobacterium spp. and Lactobacillus spp. play a key role in digestion of nutrients, production of short chain fatty acids and vitamins, inhibition of harmful bacteria, immunostimulation, reduction of blood cholesterol and ammonia levels and restoration of normal flora after antibiotic therapy. Proteolytic species such as toxin-producing clostridia and toxigenic E. coli are considered as potential pathogens with detrimental effects to human host. Recently, part of novel food research is directing towards the concept of prebiotics e.g. food ingredients that are not hydrolyzed by the human gastrointestinal tract and beneficially affect the host by selectively stimulating the growth and/or activity of one or limited number of bacteria in the colon that can improve host health. Fructo-oligosaccharides and inulin, are considered as the most extensively studied and well-established prebiotics. In vitro and in vivo data suggest the bifidogenic effect of inulin and oligofructose, which can be attributed to their selective fermentation by Bifidobacterium species. Due to their documented prebiotic properties, both inulin and FOS are increasingly applied in novel food product development through the fortification of commonly ingested foodstuffs. The aim of this study is to evaluate the in vivo prebiotic effect of a functional food containing short-chain fructo-oligosaccharides (sc-FOS) and Sideritis euboea extract on the faecal microflora composition of healthy human volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2007
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 2, 2009
CompletedFirst Posted
Study publicly available on registry
September 3, 2009
CompletedSeptember 3, 2009
September 1, 2009
5 months
September 2, 2009
September 2, 2009
Conditions
Outcome Measures
Primary Outcomes (1)
to evaluate the in vivo prebiotic effect of an jelly containing sc-FOS and Sideritis euboea extract on the faecal microflora composition and to evaluate the effect of jelly containing sc-FOS and Sideritis euboea extract on gastrointestinal symptoms
30d intervention and 2 wks follow-up
Study Arms (2)
sc-FOS+Sideritis euboea group
EXPERIMENTALJelly supplemented with short chain fructooligosaccharides and Sideritis euboea extract
placebo group
PLACEBO COMPARATORJelly without short-chain fructooligosaccharides and Sideritis euboea
Interventions
dietary supplement: jelly with 5g sc-FOS and 0.3g Sideritis euboea extract per daily portion for 30 days placebo food: jelly with no sc-FOS and Sideritis euboea
Eligibility Criteria
You may qualify if:
- Healthy adult subjects
You may not qualify if:
- History of gastrointestinal disease
- Chronic diseases (i.e.,diabetes,cardiovascular diseases, hyperlipidemia, autoimmune disorders)
- History of epileptic seizures
- Extreme dietary behaviours
- Consumption of antibiotics and other medication 2 months prior and during the investigation period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harokopio Universitylead
- Hellenic Republic Ministry of Developmentcollaborator
- Jotis S.A. Food Industrycollaborator
Study Sites (1)
Harokopio University
Kallithea, Attica, 17671, Greece
Study Officials
- STUDY DIRECTOR
Adamantini Kyriacou, Ass. Professor
Harokopio University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 2, 2009
First Posted
September 3, 2009
Study Start
April 1, 2007
Primary Completion
September 1, 2007
Study Completion
December 1, 2007
Last Updated
September 3, 2009
Record last verified: 2009-09